FIGS/$FIGS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About FIGS
FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.
- Ticker
- $FIGS
- Sector
- Consumer Discretionary
- Primary listing
- NYSE
- Employees
- 359
- Headquarters
- Santa Monica, United States
- Website
- www.wearfigs.com
FIGS Metrics
BasicAdvanced
$3.5B
65.10
$0.33
1.02
-
Price and volume
Market cap
$3.5B
Beta
1.02
52-week high
$22.31
52-week low
$7.21
Average daily volume
3.8M
Financial strength
Current ratio
4.956
Quick ratio
3.497
Long term debt to equity
0.11
Total debt to equity
0.13
Profitability
EBITDA (TTM)
78.853
Gross margin (TTM)
68.91%
Net profit margin (TTM)
8.72%
Operating margin (TTM)
9.60%
Effective tax rate (TTM)
19.20%
Revenue per employee (TTM)
$1,980,000
Management effectiveness
Return on assets (TTM)
7.75%
Return on equity (TTM)
14.76%
Valuation
Price to earnings (TTM)
65.098
Price to revenue (TTM)
4.964
Price to book
7.99
Price to tangible book (TTM)
7.99
Price to free cash flow (TTM)
36.255
Free cash flow yield (TTM)
2.76%
Free cash flow per share (TTM)
0.588
Growth
Revenue change (TTM)
24.67%
Earnings per share change (TTM)
653.94%
3-year revenue growth (CAGR)
10.11%
3-year earnings per share growth (CAGR)
60.34%
What the Analysts think about FIGS
Analyst ratings (Buy, Hold, Sell) for FIGS stock.
Analyst projections of the future price of FIGS stock.
Bulls say / Bears say
Second-quarter revenue rose 28.8% and active customers grew 13%, prompting FIGS to lift its 2026 revenue-growth outlook to about 20% from 14%–16%. That points to strong demand and a faster growth trajectory. (Nasdaq)
International revenue grew 67% in the second quarter, and FIGS now sells in 85 markets. International sales are still a small share of the business, leaving room for this channel to drive further growth if the company can build its brand abroad. (Investing.com)
FIGS has substantial financial flexibility: it ended the second quarter with $296.3 million in cash and short-term investments and no borrowings. The board also added $100 million to its share-repurchase authorisation, supporting returns to shareholders while funding expansion. (StockTitan, Nasdaq)
The 820-basis-point rise in second-quarter gross margin was largely boosted by tariff refunds: the company said they accounted for 780 basis points. That makes the headline improvement difficult to sustain once the refunds roll off. (Nasdaq)
A US import restriction affects a Jordanian supplier that made about one-third of FIGS’ second-quarter finished goods. FIGS expects the disruption to weigh on second-half revenue and margins, while shifting production and using air freight could add costs. (StockTitan)
Management’s 2026 outlook implies revenue growth easing from about 20% in the third quarter to about 10% in the fourth. That sharp step-down raises the risk that recent growth momentum will cool as comparisons get tougher. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 12 Oct 2026.
FIGS Financial Performance
Revenues and expenses
FIGS Earnings Performance
Company profitability
Upcoming events
No upcoming events
FIGS News
AllArticlesVideos
Funds containing FIGS
Fund name | Fund size | $FIGS weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.07% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.07% |
iShares MSCI World Small Cap£WLDS | $9B | 0.02% |
iShares MSCI World Small Cap€IUSN | $9B | 0.02% |
iShares MSCI World Small Cap$WSML | $9B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.